Skip to main content
. 2017 Jun 21;313(2):C228–C238. doi: 10.1152/ajpcell.00101.2017

Fig. 1.

Fig. 1.

The predicted membrane topology of human riboflavin transporter-3 (hRFVT-3). hRFVT-3 is predicted to have 11 transmembrane domains (TMDs) with intracellular NH2- and extracellular COOH-terminal tails. The predicted N-glycosylation and substrate interaction residue sites are depicted in rectangular and oval shapes, respectively.